Business Standard

Biofil Chemicals & Pharmaceuticals Share Price

Know More
BSENSE

63.63-1.37 (-2.11%)

04:01 PM,28th May 2024

63.95-1.25 (-1.92%)

03:49 PM,28th May 2024

BSE : 524396

NSE : BIOFILCHEM

Sector : Health care

ISIN Code : INE829A01014

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 28-May-2024 | 04:01 PM IST

Market Cap (₹ Cr)

104

Turnover (₹ Cr)

0.01

Volume (Shares)

13,019

Face Value

10

52-WK High

-

52-WK High Date

Invalid date

52-WK Low

-

52-WK Low Date

Invalid date

All Time High

-

All Time High Date

Invalid date

All Time Low

-

All Time Low Date

Invalid date

Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The com...
Read More

Biofil Chemicals Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>BIOFIL CHEMICALS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Shweta Verma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 25/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>BIOFIL CHEMICALS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Shweta Verma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 25/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Biofil Chemicals & Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

104

EPS - TTM (₹) [S]

0.41

P/E Ratio (X) [S]

5.89

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]10.86
P/B Ratio (₹) [S]5.89

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

63.50

65.20

Week Low/High

63.50

69.00

Month Low/High

63.50

74.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-5.39%-5.40%1.651.59%
1 Month-8.33%-8.51%1.952.09%
3 Month0.19%0.71%3.964.27%
6 Month18.71%18.98%13.5915.08%
1 Year45.77%46.51%20.2723.72%
3 Year-8.32%-8.18%46.1848.28%

Company Info

Company Information

Chairman & Managing Director : Ramesh Shah

Non Executive Director : Romil Shah

Independent Director : Shaila Jain

Independent Director : Satish Beohar

Independent Director : Ashok Kumar Ramawat

Whole-time Director : Ketan Shah

Company Sec. & Compli. Officer : Shweta Verma

Independent Director : Gayatri Padiyar

Registered Office: 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area,Indore,Madhya Pradesh-452015 Ph: 91-731-2426700

Email:bcplcompliance@gmail.com; biofilchemicals@yahoo.co

URL:http://www.biofilgroup.net

FAQs about Biofil Chemicals & Pharmaceuticals Ltd

1. What's the Biofil Chemicals & Pharmaceuticals Ltd share price today?
Biofil Chemicals & Pharmaceuticals Ltd share price was Rs 63.63 at 04:01 PM IST on 28th May 2024. Biofil Chemicals & Pharmaceuticals Ltd share price was down by 2.11% from the previous closing price of Rs 65.00. Biofil Chemicals & Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Biofil Chemicals & Pharmaceuticals Ltd share price moved down by 8.33% on BSE
  • Last 3 Months: Biofil Chemicals & Pharmaceuticals Ltd share price moved up by 0.19% on BSE
  • Last 12 Months: Biofil Chemicals & Pharmaceuticals Ltd share price moved up by 45.77% on BSE
  • Last 3 Years: Biofil Chemicals & Pharmaceuticals Ltd price moved down by 8.32% on BSE


2. How can I quickly analyse the performance of the Biofil Chemicals & Pharmaceuticals Ltd stock?
The performance of the Biofil Chemicals & Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 155.98
  • Price to book value ratio is 5.89
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Biofil Chemicals & Pharmaceuticals Ltd stock is Rs 0.41


3. What is the market cap of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd has a market capitalisation of Rs 104 crore.


4. What is Biofil Chemicals & Pharmaceuticals Ltd's 52-week high/low share price?
The Biofil Chemicals & Pharmaceuticals Ltd’s 52-week high share price is Rs - and 52-week low share price is Rs -.


5. Is the Biofil Chemicals & Pharmaceuticals Ltd profitable?
On a consolidated basis, Biofil Chemicals & Pharmaceuticals Ltd reported a profit of Rs 0.09 crore on a total income of Rs 5.06 crore for the quarter ended 2023. For the year ended Dec 2023, Biofil Chemicals & Pharmaceuticals Ltd had posted a profit of Rs 0.09 crore on a total income of Rs 5.06 crore.


6. Which are Biofil Chemicals & Pharmaceuticals Ltd’s peers in the Health care sector?
Biofil Chemicals & Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Lasa Supergeneri, Samrat Pharma, Mercury Labs, Biofil Chemicals, Everest Organics, Makers Labs., Godavari Drugs.


7. Who owns how much in Biofil Chemicals & Pharmaceuticals Ltd?
Key changes to the Biofil Chemicals & Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Biofil Chemicals & Pharmaceuticals Ltd has gone up to 46.82 per cent as of Mar 2024 from 46.82 per cent as of Jun 2023.